Delpharm Group selected for large-scale production of firibastat tablets Read the press realease
Quantum Genomics to give an exclusive license for firibastat in Greece
Quantum Genomics to give an exclusive license for firibastat in Greece Read the press realease
Boursorama – Le Journal des Biotechs: Interview with Jean-Philippe Milon (in French)
Boursorama – Le Journal des Biotechs: Interview with Jean-Philippe Milon (in French) Watch the interview
Very successfull private placement
Very successfull private placement Read the press realease
Quantum Genomics to give an exclusive license for firibastat in South Korea
Quantum Genomics to give an exclusive license for firibastat in South Korea Read the press…
Launch of a capital increase by private placement
Launch of a capital increase by private placement Read the press realease
LaTribune.fr – La Matinale de l’Entrepreneur: Interview with Jean-Philippe Milon (in French)
LaTribune.fr – La Matinale de l’Entrepreneur: Interview with Jean-Philippe Milon (in French) Watch the interview
Figaro.fr/Espace Économie – Entreprise & Innovation: Interview with Jean-Philippe Milon (in French)
Figaro.fr/Espace Économie – Entreprise & Innovation: Interview with Jean-Philippe Milon (in French) Watch the…
TV Finance.fr – Paroles de dirigeant: Interview with Jean-Philippe Milon (in French)
TV Finance.fr – Paroles de dirigeant: Interview with Jean-Philippe Milon (in French) Watch the…
Quantum Genomics to give an exclusive license for firibastat in Canada
Quantum Genomics to give an exclusive license for firibastat in Canada. Read the press…